Clinical Trial Update: Antigen-specific T Cells Against Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating antigen-specific T cells for lung cancer; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Antigen-specific T cells

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN